Efficacy and safety of trimodulin, a novel polyclonal antibody preparation, in patients with severe community-acquired pneumonia: a randomized, placebo-controlled, double-blind, multicenter, phase II trial (CIGMA study) - Welte, T; Dellinger, R P; Ebelt, H (Intensive Care Med, 2018)